EUVIMEDEUVIMED entdecken
Crossref

Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries

Marcelo Bueno de Camargo iD, Inês Ribeiro-Vaz iD, Cristiane de Cássia Bergamaschi iD, Marcus Tolentino Silva iD

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Marcelo Bueno de Camargo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pharmaceutical Sciences, University of Sorocaba, São Paulo, Brazil. Hauptthemen laut MEDLINE: Drug Hypersensitivity Syndrome, Anti-Bacterial Agents, Adverse Drug Reaction Reporting Systems. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose This study investigated the association between the use of antibiotics and the occurrence of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome, a rare and serious adverse event characterized by eosinophilia and acute skin rash. Without early diagnosis, the syndrome can lead to complications or even death.

Methods

In 2020, the Brazilian National Health Surveillance Agency (Anvisa) made available a system for reporting adverse drug events, called VigiMed. Reports of adverse events registered on this system between December 1, 2018 and December 31, 2022, were analyzed. Reporting odds ratio (ROR), together with the respective 95% confidence intervals (95% CI), was calculated as a measure of the association between antibiotics and DRESS syndrome.

Results

A total of 160,101 reports of adverse drug events were analyzed, with 136 suspected cases of DRESS syndrome. Compared with other drugs, the following frequencies of suspected DRESS syndrome were observed for the use of any antibiotic (ROR: 4.8; 95% CI: 3.3–7.0), meropenem (ROR: 13.0; 95% CI: 8.0–21.0), vancomycin (ROR: 11.5; 95% CI: 7.4–17.6), ampicillin (ROR: 6.8; 95% CI: 2.1–21.8), amoxicillin (ROR: 4.7; 95% CI: 1.5–15.0), cefepime (ROR: 4.3; 95% CI: 1.3–13.6), piperacillin + tazobactam (ROR: 2.5; 95% CI: 1.1–5.8) and ceftriaxone (ROR: 2.4; 95% CI: 1.1–5.1). The ROR for DRESS syndrome and the use of oxacillin was 2.7 with a wide 95% CI (0.7–11.1).

Conclusions

An association was observed between reports of DRESS syndrome and the use of antibiotics, particularly those routinely used in a hospital setting. Although there is a potential risk of underreporting or unattributed causality, the information obtained in this study is valuable for the analysis of rare adverse reactions. Given the seriousness of the findings, further studies should be conducted to obtain more accurate information about this adverse reaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Hypersensitivity SyndromeAnti-Bacterial AgentsAdverse Drug Reaction Reporting SystemsHumansPharmacovigilanceBrazilFemaleMaleMiddle AgedAdultRegistriesAgedYoung AdultAdolescentChildChild, PreschoolInfantAged, 80 and over

Stichwörter der Autor:innen

BrazilDrug Reaction with Eosinophilia and Systemic Symptomsantibioticsdrug hypersensitivity syndromepharmacovigilance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Graduate Program in Pharmaceutical Sciences, University of Sorocaba, São Paulo, Brazil.
  • Faculty of Medicine, University of Porto, Porto, Portugal.
  • University of Brasília (UNB), Brasilia, Brazil.

ORCID-Profile: Marcelo Bueno de Camargo, Inês Ribeiro-Vaz, Cristiane de Cássia Bergamaschi, Marcus Tolentino Silva

Zitieren

APA

de Camargo, M. B., Ribeiro-Vaz, I., de Cássia Bergamaschi, C., & Silva, M. T. (2025). Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70128

Vancouver

de Camargo MB, Ribeiro-Vaz I, de Cássia Bergamaschi C, Silva MT. Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70128

BibTeX
@article{deCamargo2025,
  author = {de Camargo, Marcelo Bueno and Ribeiro-Vaz, Inês and de Cássia Bergamaschi, Cristiane and Silva, Marcus Tolentino},
  title = {Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70128}
}
Kostenlos starten →